Besides FP-RMS, CHD4 has been implicated in the viability of other tumors such as breast cancer (D’Alesio et al., 2016), acute myeloid leukemia (Heshmati et al., 2016), lung cancer (Xu et al., 2016), and colorectal cancer (Xia et al., 2017). This evidence concerns the gene CHD4 and lung carcinoma.